Literature DB >> 25821763

Toxic epidermal necrolysis in hemodialysis patient.

Uday Venkat Mateti1, Shankar Prasad Nagaraju2, Manohar Bairy2, Ravindra Prabhu Attur2, Anantha Naik Nagappa1, Anuradha Calicut Kini Rao3.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare and life-threatening allergic drug reaction. We report a 26-year-old young female with end-stage renal disease on maintenance hemodialysis developing TEN while on filgrastim and phenytoin. It was successfully treated with intravenous immunoglobulins and steroids.

Entities:  

Keywords:  End stage renal disease; filgrastim; hemodialysis; phenytoin; toxic epidermal necrolysis

Year:  2015        PMID： 25821763      PMCID： PMC4374200          DOI： 10.4103/2277-9175.152119

Source DB:  PubMed          Journal:  Adv Biomed Res        ISSN： 2277-9175


  4 in total

1.  [Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy].

Authors:  F A Fernández; E Pintor; R Quesada; F J Garcés
Journal:  Actas Dermosifiliogr       Date:  2007-09

Review 2.  Toxic epidermal necrolysis clinical guidelines.

Authors:  Frederick W Endorf; Leopoldo C Cancio; Nicole S Gibran
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

3.  Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

Authors:  Maja Mockenhaupt; Cecile Viboud; Ariane Dunant; Luigi Naldi; Sima Halevy; Jan Nico Bouwes Bavinck; Alexis Sidoroff; Jürgen Schneck; Jean-Claude Roujeau; Antoine Flahault
Journal:  J Invest Dermatol       Date:  2007-09-06       Impact factor: 8.551

4.  Profile of antiepileptic pharmacotherapy in a tertiary referral center in South India: a pharmacoepidemiologic and pharmacoeconomic study.

Authors:  K Radhakrishnan; S D Nayak; S P Kumar; P S Sarma
Journal:  Epilepsia       Date:  1999-02       Impact factor: 5.864
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.